A collaborative consortium that collects and pools research data from patient advocacy groups, clinicians, researchers, and pharmaceutical companies to accelerate clinical treatments for rare genetic neurodevelopmental disorders.

A membership service that enables patient advocacy groups and industry advisors to collaborate, share expertise, and access resources for advancing treatments for rare genetic neurodevelopmental disorders.